GlassScriptPhysician profile
Ashley Parlavechio
NPI 1316235443
$295.89
in general payments reported to CMS, 2019-2025
11 companies · $98.80 in 2025
The $98.80 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $111 · 2022: $85.70 · 2025: $98.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $98.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $98.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $81.30 | 2025 | Cleviprex |
| Cranial Technologies, INC | $67.93 | 2021-2022 | |
| Sanofi Pasteur INC. | $27.36 | 2021-2022 | |
| Cumberland Pharmaceuticals, INC. | $18.61 | 2022 | |
| Rare Disease Therapeutics, INC. | $17.50 | 2025 | Anavip |
| Phadia US INC. | $15.19 | 2021 | |
| Galderma Laboratories, L.P. | $14.89 | 2021 | |
| Corium, LLC | $13.77 | 2022 | |
| Genentech USA, INC. | $13.64 | 2021 | |
| Kaleo, INC. | $13.24 | 2021 | |
| Adlon Therapeutics L.P. | $12.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Parlavechio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.